AtriCure, Inc. (ATRC) insider trading.
In Q3 2026, insiders at AtriCure, Inc. reported 18 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 10 sales worth $3.3M.
- Transactions
- 18
- Purchases (P)
- 0
- Sales (S)
- 10
- Net shares, P minus S
- -74,868
- Insiders
- 10
- Last filed
- 2026-09-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Privitera Salvatore | Officer · Chief Technical Officer | 4 | 0 | 3 |
| Carrel Michael H | Director, Officer · President, CEO, & Director | 3 | 0 | 0 |
| Dahlquist Karl S. | Officer · Chief Legal Officer | 2 | 0 | 1 |
| Wehrwein Sven | Director | 2 | 0 | 1 |
| Doraiswamy Vinayak | Officer · Chief Scientific Officer | 2 | 0 | 1 |
| Groves Regina E | Director | 1 | 0 | 1 |
| Prange Karen | Director | 1 | 0 | 1 |
| Yuen Maggie | Director | 1 | 0 | 1 |
| Noznesky Justin J | Officer · Chief Mktg & Strategy Officer | 1 | 0 | 1 |
| Seith Douglas J | Officer · Chief Operating Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Privitera Salvatore | S (D) | 4,519 | $60 | 142,745 | Form 4 |
| 2026-09-11 | Groves Regina E | S (D) | 5,313 | $54.22 | 34,546 | Form 4 |
| 2026-09-08 | Privitera Salvatore | S (D) | 3,657 | $55 | 147,264 | Form 4 |
| 2026-09-02 | Privitera Salvatore | S (D) | 7,763 | $52.5 | 150,921 | Form 4 |
| 2026-08-24 | Dahlquist Karl S. | S (D) | 9,370 | $48.89 | 87,319 | Form 4 |
| 2026-08-05 | Prange Karen | S (D) | 3,564 | $38.8 | 22,809 | Form 4 |
| 2026-08-05 | Yuen Maggie | S (D) | 3,500 | $38.42 | 14,015 | Form 4 |
| 2026-07-30 | Carrel Michael H | G (D) | 4,000 | $0 | 774,434 | Form 4 |
| 2026-07-30 | Carrel Michael H | G (D) | 700 | $0 | 778,434 | Form 4 |
| 2026-07-29 | Noznesky Justin J | S (D) | 6,182 | $38.8 | 100,219 | Form 4 |
| 2026-07-28 | Wehrwein Sven | M (A) | 25,000 | $19.95 | 65,518 | Form 4 |
| 2026-07-28 | Wehrwein Sven | S (D) | 25,000 | $37.84 | 40,518 | Form 4 |
| 2026-07-28 | Doraiswamy Vinayak | S (D) | 6,000 | $38.88 | 86,511 | Form 4 |
| 2026-06-30 | Carrel Michael H | A (A) | 636 | $23.78 | 779,134 | Form 4 |
| 2026-06-30 | Privitera Salvatore | A (A) | 636 | $23.78 | 158,684 | Form 4 |
| 2026-06-30 | Seith Douglas J | A (A) | 527 | $23.78 | 229,867 | Form 4 |
| 2026-06-30 | Dahlquist Karl S. | A (A) | 636 | $23.78 | 96,689 | Form 4 |
| 2026-06-30 | Doraiswamy Vinayak | A (A) | 636 | $23.78 | 92,511 | Form 4 |
Transaction codes in this quarter
Get ATRC insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1323885&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ATRC company page · AtriCure, Inc. on SEC.gov
Questions
Are insiders buying or selling AtriCure, Inc. (ATRC)?
In Q3 2026, insiders at AtriCure, Inc. reported 18 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 10 sales worth $3.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these AtriCure, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/atrc.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.